Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin dose reduction in neuropathic pain: variability and effect size
2004-004837-33Phase 4Completed
- Sponsor
- Pfizer
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of gabapentin in Neuralgia (2 arms), sponsored by Pfizer. Primary endpoint: Average daily pain score after 4 weeks. Started Mar 2005; status: completed.
02
Drugs
gabapentin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2004-004837-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004837-33.